SRSA
S.R. Schill & Associates’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-565
| Closed | -$350K | – | 36 |
|
|
2024
Q3 | $350K | Sell |
565
-1,622
| -74% | -$1M | 0.25% | 25 |
|
|
2024
Q2 | $1.21M | Buy |
2,187
+857
| +64% | +$474K | 0.53% | 23 |
|
|
2024
Q1 | $773K | Sell |
1,330
-207
| -13% | -$120K | 0.34% | 35 |
|
|
2023
Q4 | $816K | Buy |
1,537
+792
| +106% | +$420K | 0.36% | 30 |
|
|
2023
Q3 | $377K | Sell |
745
-70
| -9% | -$35.4K | 0.18% | 56 |
|
|
2023
Q2 | $425K | Buy |
815
+325
| +66% | +$170K | 0.19% | 47 |
|
|
2023
Q1 | $282K | Buy |
490
+9
| +2% | +$5.19K | 0.13% | 62 |
|
|
2022
Q4 | $265K | Sell |
481
-128
| -21% | -$70.5K | 0.13% | 65 |
|
|
2022
Q3 | $309K | Buy |
609
+103
| +20% | +$52.3K | 0.16% | 47 |
|
|
2022
Q2 | $275K | Buy |
+506
| New | +$275K | 0.14% | 53 |
|
|
2022
Q1 | – | Sell |
-385
| Closed | -$257K | – | 80 |
|
|
2021
Q4 | $257K | Buy |
385
+20
| +5% | +$13.4K | 0.1% | 69 |
|
|
2021
Q3 | $209K | Buy |
+365
| New | +$209K | 0.09% | 85 |
|
|
2021
Q2 | – | Sell |
-1,700
| Closed | -$776K | – | 96 |
|
|
2021
Q1 | $776K | Buy |
1,700
+213
| +14% | +$97.2K | 0.34% | 38 |
|
|
2020
Q4 | $693K | Buy |
1,487
+432
| +41% | +$201K | 0.32% | 38 |
|
|
2020
Q3 | $466K | Sell |
1,055
-524
| -33% | -$231K | 0.24% | 47 |
|
|
2020
Q2 | $572K | Buy |
1,579
+64
| +4% | +$23.2K | 0.33% | 41 |
|
|
2020
Q1 | $430K | Sell |
1,515
-455
| -23% | -$129K | 0.29% | 41 |
|
|
2019
Q4 | $640K | Buy |
1,970
+4
| +0.2% | +$1.3K | 0.35% | 46 |
|
|
2019
Q3 | $573K | Sell |
1,966
-1
| -0.1% | -$291 | 0.32% | 45 |
|
|
2019
Q2 | $578K | Buy |
1,967
+586
| +42% | +$172K | 0.36% | 46 |
|
|
2019
Q1 | $378K | Sell |
1,381
-29
| -2% | -$7.94K | 0.23% | 61 |
|
|
2018
Q4 | $316K | Sell |
1,410
-12
| -0.8% | -$2.69K | 0.22% | 62 |
|
|
2018
Q3 | $347K | Buy |
+1,422
| New | +$347K | 0.21% | 67 |
|